BioSpace News Archive

Xentria Inc. today announced that the U.S. Food and Drug Administration (“FDA”) has confirmed that the Company satisfactorily addressed all requirements and can proceed with initiation of the planned Phase 1 clinical trial of XTMAB-16.

Nordic Nanovector ASA announces encouraging initial results from the LYMRIT 37-05 Phase 1 trial investigating Betalutin® in patients with relapsed/refractory diffuse large B-cell lymphoma not eligible for stem cell transplantation.

Algenex SL, a biotech company backed by Cleon Capital and Columbus Ventures delivering disruptive technologies for recombinant biologics production, has taken significant steps towards full commercialisation of its CrisBio® platform through the first recommendation for approval by a global regulator of a biological produced with the system.

Transparency Market Research has published a new report titled, “neurorehabilitation devices market”.

Transparency Market Research has published a new report titled, ‘Myasthenia Gravis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

The growth of the global cell separation market is estimated to be driven by the growing interest of scientists and biotechnology companies in stem cell research.

Transparency Market Research has published a new report titled, ‘Alpha mannosidosis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

Agilent Technologies Inc. announced the launch of three InfinityLab Bio LC systems specifically developed to meet the needs of the biopharma industry.

THREAD, a technology and service provider enabling decentralized clinical trials (“DCTs”), today announced the launch of a new offering, THREAD DESIGN.

Guardant Health, Inc. (Nasdaq: GH) adds two new products to its portfolio to help improve the management of patients with late-stage and metastatic cancers